Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Novartis inks $3.2B subcutaneous drug delivery deal with Alteogen

Novartis inks $3.2B subcutaneous drug delivery deal with Alteogen

  • September 2, 2026

Novartis has struck a deal worth up to $3.2 billion to work with Alteogen on subcutaneous drug delivery, joining Biogen and GSK on the list of drugmakers to pay to access the technology this year.

Leave A Comment

Fields (*) Mark are Required